Monthly News May 2012
 |
Swiss Biotech Industry: high level of performance despite currency effects
3 April 2012 – 2011 was a surprisingly good year for the Swiss biotech industry, despite negative currency effects
and the continuing economic weakness which affected all export-driven industries. The signs are nevertheless positive.
For example, the volume of investment in private and listed Swiss biotech companies increased sharply compared with the
previous year.
News release (HTML, German)
Report (PDF, English, 3583 kB)
|
|
|
|
| Related content |
| Subscribe |
|
You can subscribe to this and future newsletters from Ernst & Young by clicking on
|
|
|
|
|